Isu Abxis Attracts Individual Investors' Attention... Stock Price Up 2.83%...
Recently, the search frequency for Isu Abxis, known as a company under the Isu Group affiliate that develops antibiotic treatments and provides medical services, has surged.
As of 11:32 AM on the 16th, Isu Abxis's stock price rose 2.83% from the previous day to 14,550 KRW, with a trading volume of 14,728,060 shares, which is 200.97% of the 5-day average trading volume. Today, foreigners are tentatively recorded as net sellers of 15,000 shares.
On February 10th, Isu Abxis was an issue in the market with the news of 'Strong performance due to Russian COVID-19 vaccine contract manufacturing.'
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Bull Market End Signal? Securities Firm Warns: "Sell SK hynix 'At This Moment'"
- "Looks Even More Like Him in Person": Crowds Gather to See 'Trump Lookalike' Albino Buffalo
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
